About Wende Hutton
Form D filings for Antiva Biosciences from 2015 to 2024 list Wende Hutton as director.
Wende Hutton first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Wende Hutton in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Wende Hutton works with at each company, as listed on that company's latest Form D.
Antiva Biosciences, Inc. · Form D/A, Oct 11, 2024
CS
Clifford Samuel
Director
BR
Beni Rovinski
Director
FS
Florencia Segal
Director
GM
Gail Maderis
Director
KB
Kristine Ball
Chief Executive Officer and director
EC
Elaine Chien
Executive officer
BG
Brian Goodman
Director
SW
Sarah Walter
Executive officer
RG
Raju Gadiraju
Executive officer